This is a historical report — it no longer reflects this drug's current status. Current status: Anticipated Shortage. View this drug's full profile page →

Resolved

ESTRADOT 25

SANDOZ CANADA INCORPORATED

View this drug's full profile page →

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of ESTRADOT 25 in Canada?

A shortage of ESTRADOT 25 25MCG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated November 2, 2026), but it has not started yet.

Why is ESTRADOT 25 not available?

The reason the manufacturer reported: Delay in shipping of the drug.

When will ESTRADOT 25 be available again?

The manufacturer's estimated resolution date is January 22, 2027. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Check with your pharmacist

StatusResolved

Same-ingredient products on fileNone found

Affected strength25MCG

Report last updated2026-06-16

Checked by MedShort2026-11-13

What this means

Does this mean the shortage is completely over everywhere?

It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.

What should I do?

If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02245676

Strength

25MCG

Dosage Form

PATCH

Route

TRANSDERMAL

Active Ingredient

ESTRADIOL

Tier

Unrated

Last Updated

2026-06-16

Reason for Shortage

Disruption of the manufacture of the drug.

Source

View original report on healthproductshortages.ca ↗

Past Reports for This Drug

ESTRADOT 25 has 3 shortage/discontinuation reports on file — this is one of them.

2026-11-02

Anticipated Shortage

Delay in shipping of the drug.

2026-11-02

Resolved

Disruption of the manufacture of the drug.

Other Products from SANDOZ CANADA INCORPORATED

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ACETYLCYSTEINE SOLUTION

200MG · DIN 02243098

ACLASTA

5MG · DIN 02269198

ALFENTANIL INJECTION USP

500MCG · DIN 02248181

AMIKACIN SULFATE INJECTION USP

250MG · DIN 02242971

AMIODARONE HYDROCHLORIDE FOR INJECTION

50MG · DIN 02242325

AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION

DIN 02495929